Pain management devices market seen reaching $7.38 billion by 2030

The pain management devices and therapies market is projected to grow from $5.75 billion in 2026 to $7.38 billion by 2030, driven by chronic pain cases, aging populations and demand for non-opioid options. North America led the market in 2025, while neurostimulation and minimally invasive treatments are among the main growth themes.

Why it matters: - Rising chronic pain rates are increasing demand for targeted, non-opioid treatment options. - The market is moving toward device-based therapies that can provide longer-term relief with less reliance on medication. - Growth in outpatient care and minimally invasive procedures is widening the addressable market.

What happened: - The pain management devices and therapies market is projected to rise from $5.34 billion in 2025 to $5.75 billion in 2026. - The market is forecast to reach $7.38 billion by 2030. - That implies a 6.4% CAGR over the forecast period. - The market’s recent growth was driven by chronic pain prevalence, more cancer-related pain cases, opioid-use concerns, neurological treatment advances and broader hospital adoption of pain stimulators. - The Business Research Company published the market outlook on Aug. 21, 2026. - View the full pain management devices and therapies market report

The details: - Pain management devices and therapies are used to relieve chronic and severe pain tied to cancer and neurological disorders. - Main applications include spinal cord stimulation, sacral nerve stimulation and deep brain stimulation. - The market’s longer-term growth is supported by an aging population, neurostimulator innovation, rising demand for sustained pain relief, growth in outpatient pain treatment facilities and higher healthcare spending. - Key trends include broader acceptance of neurostimulation therapies, a shift to non-opioid pain management, more implantable pain devices, stronger demand for chronic pain treatments and increased use of minimally invasive procedures. - North America held the largest regional share in 2025. - Western Europe ranked second in 2025. - Other regions covered include Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated technology and trend analysis. - The report also includes updated graphics and tables.

Between the lines: - Chronic pain is becoming a larger public health burden as populations age. - The growth outlook suggests buyers and providers are still willing to invest in device-based alternatives even as opioid concerns reshape pain treatment. - The emphasis on neurostimulation and implantable devices points to a market that is becoming more specialized and technology-led.

What's next: - The market’s next phase will likely hinge on adoption of neurostimulation therapies and outpatient treatment models. - Demand should continue rising if healthcare systems keep prioritizing non-opioid pain management. - The company also made a free sample report available through its website: Download a free sample

The bottom line: - Pain management devices and therapies are on track for steady growth through 2030, with chronic pain, aging populations and non-opioid treatment demand doing the heavy lifting.